Insulinoma-related Endogenous Hypoglycaemia with a Negative Fasting Test: A Case Report and Literature Review

  • Carolina Prieto-Saldarriaga Endocrinology, Hospital Pablo Tobón Uribe, Medellín, Colombia; Universidad Pontificia Bolivariana, Medellín, Colombia
  • Carlos Esteban Builes-Montaño Endocrinology, Hospital Pablo Tobón Uribe, Medellín, Colombia; Endocrinology, Department of Internal Medicine. Universidad de Antioquia, Medellín, Colombia
  • Clara Maria Arango-Toro Endocrinology, Hospital Pablo Tobón Uribe, Medellín, Colombia; Endocrinology, Department of Internal Medicine. Universidad de Antioquia, Medellín, Colombia
  • Cindy Manotas-Echeverry Department of Internal Medicine. Universidad del Norte, Barranquilla, Colombia
  • Juan Camilo Pérez-Cadavid Endocrinology, Hospital Pablo Tobón Uribe, Medellín, Colombia; Endocrinology, Department of Internal Medicine, Universidad de Antioquia, Medellín, Colombia; Patología SURA-IPS, Medellín, Colombia
  • José C Álvarez-Payares Department of Internal Medicine, Universidad de Antioquia, Medellín, Colombia
  • Luis Antonio Rodriguez Arrieta Endocrinology, Department of Internal Medicine, Universidad de Antioquia, Medellin, Colombia
DOI: https://doi.org/10.12890/2022_003484

Keywords

Insulinoma, hyperinsulinaemia, fasting

Abstract

We present the case of a patient with a history of symptomatic hypoglycaemic episodes and a negative 72-hour fasting test with histological confirmation of insulinoma. A literature review of hyperinsulinaemic hypoglycaemia with a negative fasting test was performed.

VIEW THE ENTIRE ARTICLE

References

  • Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol 2013;19(6):829–837. doi: 10.3748/wjg.v19.i6.829.
  • Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma–Incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991;66:711–719.
  • Morera J, Reznik Y. Insulinome [Insulinoma]. Rev Prat 2019;69(7):e250. French.
  • Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin North Am 2009;89(5):1105–1121. doi: 10.1016/j.suc.2009.06.009.
  • Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab 2009;94:1069–1073.
  • van Bon AC, Benhadi N, Endert E, Fliers E, Wiersinga WM. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma. Neth J Med 2009;67(7):274–278. PMID: 19687521.
  • Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab 2000;85:3973–3974.
  • Sjoberg RJ, Kidd GS. Case report: a glucose responsive insulinoma–implication for the diagnosis of insulin secreting tumors. Am J Med Sci 1992;304(3):164–167. doi: 10.1097/00000441-199209000-00004.
  • Wiesli P, Schmid C, Perren A, Pfammatter T, Spinas GA, Keller U. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties. J Endocrinol Invest 2004;27(9):832–838. doi: 10.1007/BF03346277. PMID: 15648547.
  • Soh AW, Kek PC. Insulinoma in a patient with normal results from prolonged fast and glucagon-induced hypoglycemia. Endocr Pract 2010;16(5):838–841. doi: 10.4158/EP10073.CR.
  • Toaiari M, Davì MV, Dalle Carbonare L, Boninsegna L, Castellani C, Falconi M, et al. Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas. J Endocrinol Invest 2013;36(9):753–758. doi: 10.3275/8942.
  • Tobón-Ospina C, Castaño P, Gutiérrez-Restrepo J, Torres-Grajales JL, Hoyos-Duque SI, Pérez-Cadavid JC, et al. Descripción de la experiencia en pacientes diagnosticados con insulinoma. Estudio multicéntrico en Medellín, Colombia. Iatreia 2020;33(2):133–142.
  • Li X, Zhang F, Chen H, Yu H, Zhou J, Li M, et al. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test. Endocr J 2017;64(1):49–57. doi: 10.1507/endocrj.EJ16-0292.
  • Gu W, Liu Y, Liu H, Yang G, Guo Q, Du J, et al. Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma. Diabetol Metab Syndr 2017;9:17. doi: 10.1186/s13098-017-0215-3.
  • Ma J, Huang X, Zhao J, Lu J, Lu W, Bao Y, et al. CGM for insulinoma screening: a prospective and observational case-control study. Endocr Relat Cancer 2021;28(5):291–300. doi: 10.1530/ERC-20-0447.

    • Published: 2022-09-09

    Issue: 2022: Vol 9 No 9 (view)

    Section: Articles

    How to cite:
    1.
    Prieto-Saldarriaga C, Builes-Montaño CE, Arango-Toro CM, Manotas-Echeverry C, Pérez-Cadavid JC, Álvarez-Payares JC, Rodriguez Arrieta LA. Insulinoma-related Endogenous Hypoglycaemia with a Negative Fasting Test: A Case Report and Literature Review. EJCRIM 2022;9 doi:10.12890/2022_003484.